During the past decade, Nemocnice Jablonec nad Nisou conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nemocnice Jablonec nad Nisou" are "Cancer" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Nemocnice Jablonec nad Nisou" in a lesser frequency.

Most popular intervention types in "Nemocnice Jablonec nad Nisou" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Darolutamide (Nubeqa, BAY1841788)" (1 trials) and "MMX mesalamine/ mesalazine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Jablonec nad Nisou" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nemocnice Jablonec nad Nisou". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Nemocnice Jablonec nad Nisou, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Jablonec nad Nisou, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".